Literature DB >> 3380350

Increased erythrocyte susceptibility to lipid peroxidation in human Parkinson's disease.

A Kilinç1, A S Yalçin, D Yalçin, Y Taga, K Emerk.   

Abstract

Recent evidence suggests that among the factors that lead to neurodegenerative changes in Parkinson's disease are stimulation of lipid peroxidation and deficiency of glutathione and glutathione peroxidase in substantia nigra. We have investigated the effect of neurodegenerative changes on plasma and erythrocytes of patients with Parkinson's disease and compared the results with those of age-matched controls. Both plasma lipid peroxide levels and erythrocyte susceptibility to lipid peroxidation were significantly increased in Parkinson's disease. Erythrocyte fragility tests revealed that in 35% of the patients there was increased fragility. In addition, erythrocyte catalase activities were not changed whereas glutathione levels and glutathione peroxidase activities were decreased in Parkinson's disease. Our results suggest that erythrocyte membrane integrity may be impaired in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3380350     DOI: 10.1016/0304-3940(88)90467-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Glutathione peroxidase in early and advanced Parkinson's disease.

Authors:  P Johannsen; G Velander; J Mai; E B Thorling; E Dupont
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

2.  Effect of vitamin E deficiency on rat brain monoamine metabolism.

Authors:  K Adachi; M Izumi; T Mitsuma
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

3.  Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease.

Authors:  Burcu Gökçe Çokal; Mustafa Yurtdaş; Selda Keskin Güler; Hafize Nalan Güneş; Ceyla Ataç Uçar; Bilal Aytaç; Zahide Esra Durak; Tahir Kurtuluş Yoldaş; İlker Durak; Hikmet Can Çubukçu
Journal:  Neurol Sci       Date:  2016-11-30       Impact factor: 3.307

4.  The clinical significance of cerebrospinal fluid lipid peroxides in central nervous system disease.

Authors:  M Kitagawa; K Kanayama; T Sakai
Journal:  Vet Res Commun       Date:  2006-02       Impact factor: 2.459

Review 5.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

6.  Association between Anemia and Risk of Parkinson Disease.

Authors:  Yao-Chin Wang; Abel Po-Hao Huang; Sheng-Po Yuan; Chu-Ya Huang; Chieh-Chen Wu; Tahmina Nasrin Poly; Suleman Atique; Woon-Man Kung
Journal:  Behav Neurol       Date:  2021-07-07       Impact factor: 3.342

7.  Newly Diagnosed Anemia Increases Risk of Parkinson's disease: A Population-Based Cohort Study.

Authors:  Chien Tai Hong; Yao Hsien Huang; Hung Yi Liu; Hung-Yi Chiou; Lung Chan; Li-Nien Chien
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

Review 8.  Not All Stressors Are Equal: Mechanism of Stressors on RPE Cell Degeneration.

Authors:  Yao Tong; Shusheng Wang
Journal:  Front Cell Dev Biol       Date:  2020-11-19

Review 9.  Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal.

Authors:  Antonio Ayala; Mario F Muñoz; Sandro Argüelles
Journal:  Oxid Med Cell Longev       Date:  2014-05-08       Impact factor: 6.543

10.  Oxidative pathology and AQP4 mRNA expression in patients of Parkinson's disease in Tamil Nadu.

Authors:  Thamizh Thenral Subburaman; A J Vanisree
Journal:  Ann Neurosci       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.